Meritage Portfolio Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-34,411
Closed -$3.83M 252
2019
Q4
$3.83M Sell
34,411
-566
-2% -$58.2K 0.34% 96
2019
Q3
$3.47M Sell
34,977
-16,467
-32% -$1.64M 0.33% 92
2019
Q2
$5.1M Sell
51,444
-9,022
-15% -$861K 0.52% 56
2019
Q1
$6.67M Sell
60,466
-2,460
-4% -$257K 0.68% 38
2018
Q4
$5.79M Sell
62,926
-1,795
-3% -$182K 0.66% 40
2018
Q3
$7.13M Sell
64,721
-948
-1% -$98.7K 0.65% 38
2018
Q2
$6.13M Sell
65,669
-1,688
-3% -$145K 0.6% 51
2018
Q1
$5.59M Sell
67,357
-595
-0.9% -$52.9K 0.54% 72
2017
Q4
$6.19M Sell
67,952
-1,166
-2% -$97K 0.59% 60
2017
Q3
$5.26M Buy
69,118
+336
+0.5% +$25.4K 0.52% 87
2017
Q2
$5.16M Sell
68,782
-618
-0.9% -$42.8K 0.53% 85
2017
Q1
$4.53M Buy
+69,400
New +$4.09M 0.47% 102

Other funds holding PRAH

Meritage Portfolio Management's PRAH Position: Q1 2020 in Review

Meritage Portfolio Management sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2020, closing a stake of 34,411 shares — an estimated $3.83M sold.

Meritage Portfolio Management first reported a position in PRAH in Q1 2017 and held it in 12 quarters. The position peaked at $7.13M in Q3 2018. 301 funds tracked by Wall St. Rank hold PRAH as of Q1 2020.

  • Meritage Portfolio Management reported no remaining PRA Health Sciences, Inc. position as of Q1 2020 after selling out during the quarter.
  • Meritage Portfolio Management sold 34,411 PRA Health Sciences, Inc. shares in Q1 2020, an estimated $3.83M.
  • Meritage Portfolio Management first reported a position in PRA Health Sciences, Inc. in Q1 2017 and held it in 12 quarters.
  • Meritage Portfolio Management's PRA Health Sciences, Inc. position peaked at $7.13M in Q3 2018.
  • 301 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2020.

Based on Meritage Portfolio Management's 13F filing for Q1 2020, filed 27 Apr 2020.